Lantheus Medical announced Monday that the international radiopharmaceutical company has entered an agreement with Wisconsin-based Shine Medical Technologies for supply of molybdenum-99 (Mo-99).

Hospital adds multiple mobile and full room DR solutions to increase productivity and generate industry-leading MUSICA image quality for both inpatient and outpatient departments.

 Diagnostic Imaging of Salem (DIOS), a multi-modality outpatient imaging and women's center in Salem, Ore., deployed eRAD PACS and Mammography Module to achieve cost savings and productivity gains.

Responding to calls to offer payment for 3D mammography, or digital breast tomosynthesis (DBT), the Centers for Medicare & Medicaid Services (CMS) established two new add-on codes that will go into effect Jan. 1, 2015, and extend additional payment when DBT is performed along with 2D digital mammography.

A spike in regulatory requirements has been reported by Regulatory Focus according to data released by George Mason University's Mercatus Center for market research in Arlington, Va. According to the numbers, FDA requirements picked up 15 percent from the year 2000 until 2012.

Here is more incentive to bring investigative Alzheimer’s treatments to maturity—approximately a quarter of caregivers with a family member diagnosed with Alzheimer’s disease or another dementia end up paying out $4,000 in disease-related costs on a monthly basis, according to a survey released today from AgingCare.com

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) today released a statement from Bayer HealthCare dated Oct. 21 providing more information to healthcare professionals about the ongoing shortfall in Ra-223 dichloride (Xofigo) prescribed for castration-resistant prostate cancer with metastases to the bone.

Three biomedical companies from across the globe are banding together with research institutions to develop knowledge about a “super-family” of protein receptors called G-protein coupled receptors (GPCRs). Images of these biomarkers could open the door to a new era of pharmaceuticals.